Freeze-drying method and freeze-drying protective agent for mesenchymal stem cell exosome

By using dextran and hyaluronic acid as lyophilized protective agents and lyophilized under specific conditions, the problem of loss of activity during lyophilization is solved, and the long-term preservation and biological of exosomes are achieved. Activity maintenance, suitable for large-scale automated production.

CN118995588APending Publication Date: 2024-11-22SHENZHEN HUIXIN LIFE TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411021775.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, exosomes are easily destroyed during lyophilization, resulting in loss of activity and difficulty in preservation, which limits their use in experimental and clinical applications.

Method used

Dextran and hyaluronic acid are used as lyophilization protectors, through specific dilution and lyophilization procedures, including equilibration at 4°C, prefreezing at -70°C and vacuum of 0-10pa, temperatures of -50 to -40°C lyophilized under conditions to maintain the structure and biological activity of the exosomes.

Benefits of technology

It realizes long-term preservation of exosomes, maintains its structure and biological activity, is suitable for large-scale automated production, and is in line with the sterile preparation process.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a freeze-drying method of mesenchymal stem cell exosomes and a freeze-drying protective agent.The freeze-drying method comprises the following steps that a prepared exosome-free culture medium is added into a culture flask, mesenchymal stem cells are inoculated, and supernate is collected after culture; centrifuging the supernatant, collecting the centrifuged supernatant, and filtering to obtain a filtrate; centrifuging the filtrate, removing supernate, and then, carrying out resuspension to obtain resuspension liquid; and diluting the resuspension, adding a freeze-drying protective agent, fully and uniformly mixing, and freeze-drying to obtain the mesenchymal stem cell exosome freeze-dried powder. The freeze-drying method of the mesenchymal stem cell exosome accords with a sterile preparation process and can be suitable for large-scale automatic production. The prepared mesenchymal stem cell exosome freeze-dried powder can maintain the structure and biological activity of the exosome and can be stored for a long time.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biotechnology, and in particular to a freeze-drying method and a freeze-drying protective agent for mesenchymal stem cell exosomes. Background Art

[0002] Exosomes are a type of vesicles secreted by cells outside the cell. They are 30-150nm in size, have a double-layer membrane structure and a saucer-shaped morphology. Exosomes are widely present in cell culture supernatants and various body fluids, including blood, lymph, saliva, urine, tears, milk, etc. They are also present in tissue samples, such as brain tissue, muscle tissue, adipose tissue, etc. Exosomes contain cell-specific proteins, lipids and nucleic acids, which can be transmitted to other cells as signal molecules to change the functions of other cells. They play an important role in immune antigen presentation, tumor growth and migration, and repair of tissue damage. Therefore, exosomes have very broad application prospects in tissue regeneration, clinical diagnosis, and medical aesthetics and anti-aging.

[0003] Most exosome products have a very short shelf life and require very harsh storage conditions, which limits the application of exosome preparations. The traditional method of preserving exosomes is to directly freeze them at -80°C, but as the storage time increases, the bimolecular membrane of the exosomes gradually breaks down and the activity is greatly lost, making them difficult to use in experiments and clinical applications.

[0004] Freeze-drying is a process of vacuum freezing and extracting water from materials under low temperature and high pressure, so that the active ingredients can be stored at room temperature. However, during the freeze-drying process, an osmotic pressure imbalance will occur and ice crystals will form inside the biological particles, which can easily destroy the exosome phospholipid membrane, causing vesicle condensation and phase transition. Summary of the invention

[0005] In order to solve the problems of the prior art, the present application provides a freeze-drying method and freeze-drying protective agent for mesenchymal stem cell exosomes. The technical solution is as follows:

[0006] In a first aspect, a freeze-drying method for mesenchymal stem cell exosomes is provided, comprising the following steps:

[0007] Add the prepared exosome-free culture medium to the culture flask, inoculate mesenchymal stem cells, and collect the supernatant after culture;

[0008] Centrifuging the supernatant, collecting the supernatant after centrifugation, and filtering to obtain a filtrate;

[0009] Centrifuging the filtrate, removing the supernatant and resuspending to obtain a resuspended liquid;

[0010] The resuspension is diluted, and then a freeze-drying protective agent is added, and the mixture is fully mixed and freeze-dried to obtain freeze-dried mesenchymal stem cell exosome powder.

[0011] Furthermore, the lyoprotectant includes dextran and hyaluronic acid.

[0012] Furthermore, the amount of dextran is 5%-10% of the final concentration of the resuspension after dilution, and the amount of hyaluronic acid is 1%-4% of the final concentration of the resuspension after dilution.

[0013] Furthermore, the freeze-drying procedure is as follows: the freeze dryer is balanced at 4°C for 2-3 hours, pre-frozen at -70°C for 6-8 hours, and then freeze-dried for 60-72 hours at a vacuum degree of 0-10 Pa and a temperature of -50 to -40 degrees.

[0014] Furthermore, the amount of the exosome-free culture medium is 25-35 ml.

[0015] Furthermore, the seeding density of the mesenchymal stem cells is 7000-10000 cells / cm 2 .

[0016] Furthermore, the culture conditions of the mesenchymal stem cells are: saturated humidity, 5% CO 2 , culture at 37℃ for 3-4 days until the cells cover the bottom of the culture flask.

[0017] Furthermore, the supernatant is centrifuged at 10000-12000 g for 30-60 min at 4°C.

[0018] Furthermore, the supernatant after centrifugation is filtered using a 0.22 μm filter.

[0019] Furthermore, the filtrate is centrifuged at 100,000-120,000 g for 60-80 min.

[0020] Furthermore, the supernatant was removed and the mixture was resuspended in physiological saline.

[0021] Further, the resuspension was diluted with physiological saline to a concentration of 10 8 -10 9 Particles / ml.

[0022] In a second aspect, a lyophilization protectant is provided, comprising dextran and hyaluronic acid, wherein the amount of dextran is 5%-10% of the final concentration of the lyophilized liquid, and the amount of hyaluronic acid is 1%-4% of the final concentration of the lyophilized liquid.

[0023] The beneficial effects of the technical solution provided in the embodiment of the present application are as follows: the present application adds a prepared exosome-free culture medium to a culture bottle, inoculates mesenchymal stem cells, and collects the supernatant after culture; the supernatant is centrifuged, the supernatant after centrifugation is collected, and filtered to obtain a filtrate; the filtrate is centrifuged, the supernatant is removed and then resuspended to obtain a resuspended liquid; the resuspended liquid is diluted, and then a lyophilization protective agent is added, and the mixture is fully mixed and then freeze-dried to obtain a mesenchymal stem cell exosome freeze-dried powder. The freeze-drying method of the mesenchymal stem cell exosomes of the present application complies with the aseptic preparation process and can be applied to large-scale automated production. The prepared mesenchymal stem cell exosome freeze-dried powder can maintain the structure and biological activity of the exosomes and can be stored for a long time. DETAILED DESCRIPTION

[0024] In order to make the objectives, technical solutions and advantages of the present application clearer, the implementation methods of the present application will be described in further detail below.

[0025] Example 1 Umbilical cord mesenchymal stem cell exosome freeze-dried powder

[0026] A. Exosome source acquisition

[0027] Add 35 ml of prepared exosome-free culture medium (including DMEM culture medium, vitamins, recombinant cytokines, recombinant albumin, etc.) to a T175 culture flask, and the seeding density is 7000 cells / cm 2 Mesenchymal stem cells were placed in a humidified, 5% CO 2 , culture at 37°C for 3-4 days until the cells cover the bottom of the culture flask, and collect the supernatant.

[0028] DMEM culture medium includes: 1000ml of sterile deionized water, 1000mg of D-glucose, 548mg of L-glutamine, 100 units / ml of penicillin / streptomycin, 10ml of mycolipid antibiotic mixture (cyanamide phenylarsine and riboflavin ketone), 10ml of penicillin / streptomycin antibiotic mixture, 660mg of lactic acid, 200mg of sodium sulfoxide, 2ml of high amino acids (L-glutamic acid, L-lazine, L-leucine, L-isoleucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-arginine, L-histidine, L-valine), 4mg of L-cystine, 392mg of sodium hyaluronate, 10ml of vitamin solution (1X), 10ml of essential amino acid solution, 10ml of non-essential amino acid solution, and 10% of calf serum.

[0029] B. Supernatant pretreatment

[0030] The collected supernatant was placed in a low-temperature centrifuge and centrifuged at 10,000 g for 60 min at 4°C. The supernatant was collected after centrifugation and filtered through a 0.22 μm filter to obtain a filtrate.

[0031] C. Exosome Purification

[0032] The filtrate was added to an ultracentrifuge tube and centrifuged at 100,000 x g for 80 min. After centrifugation, the supernatant was removed, and then physiological saline was added to dissolve the precipitate and resuspend it to obtain a resuspended solution.

[0033] D. Particle Measurement

[0034] The particle concentration and particle size of the resuspended solution were measured using nanoparticle tracking analysis. Based on the measured particle concentration, the suspension was further diluted with saline to 10 8 Concentration of particles / ml.

[0035] E. Lyophilization of exosomes

[0036] Add 5% dextran and 1% hyaluronic acid as freeze-drying protective agents to the diluted resuspension, mix thoroughly, and place at 4°C for 2 hours. Then divide into sterilized vials and place in a freeze dryer for freeze drying. Pre-freeze at -70°C for 6 hours, and then freeze-dry for 72 hours at a vacuum degree of 0-10pa and a temperature of -40°C to obtain freeze-dried mesenchymal stem cell exosomes.

[0037] Example 2 Umbilical cord mesenchymal stem cell exosome freeze-dried powder

[0038] A. Exosome source acquisition

[0039] Add 35 ml of prepared exosome-free culture medium to a T175 culture flask, with an inoculation density of 10,000 cells / cm 2 Mesenchymal stem cells were placed in a humidified, 5% CO 2 , culture at 37°C for 3-4 days until the cells cover the bottom of the culture flask, and collect the supernatant.

[0040] B. Supernatant pretreatment

[0041] The collected supernatant was placed in a low-temperature centrifuge and centrifuged at 12000g for 30 min at 4°C. The supernatant was collected after centrifugation and filtered through a 0.22 μm filter to obtain a filtrate.

[0042] C. Exosome Purification

[0043] The filtrate was added to an ultracentrifuge tube and centrifuged at 120,000 x g for 60 min. After centrifugation, the supernatant was removed, and then physiological saline was added to dissolve the precipitate and resuspended to obtain a resuspended solution.

[0044] D. Particle Measurement

[0045] The particle concentration and particle size of the resuspended solution were measured using nanoparticle tracking analysis. Based on the measured particle concentration, the suspension was further diluted with saline to 10 9 Concentration of particles / ml.

[0046] E. Lyophilization of exosomes

[0047] Add 10% dextran and 4% hyaluronic acid as freeze-drying protective agents to the diluted resuspension, mix thoroughly, and place at 4°C for 2 hours. Then dispense into sterilized vials and place in a freeze dryer for freeze drying, pre-freeze at -70°C for 8 hours, and then freeze-dry for 60 hours at a vacuum degree of 0-10pa and a temperature of -50°C to obtain freeze-dried mesenchymal stem cell exosomes.

[0048] Example 3 Umbilical cord mesenchymal stem cell exosome freeze-dried powder

[0049] A. Exosome source acquisition

[0050] Add 35 ml of prepared exosome-free culture medium to a T175 culture flask, with an inoculation density of 80,000 cells / cm 2 Mesenchymal stem cells were placed in a humidified, 5% CO 2 , culture at 37°C for 3-4 days until the cells cover the bottom of the culture flask, and collect the supernatant.

[0051] B. Supernatant pretreatment

[0052] The collected supernatant was placed in a low-temperature centrifuge and centrifuged at 11000g for 45 minutes at 4°C. The supernatant was collected after centrifugation and filtered through a 0.22 μm filter to obtain a filtrate.

[0053] C. Exosome Purification

[0054] The filtrate was added to an ultracentrifuge tube and centrifuged at 110,000 x g for 70 min. After centrifugation, the supernatant was removed, and then physiological saline was added to dissolve the precipitate and resuspend it to obtain a resuspended solution.

[0055] D. Particle Measurement

[0056] The particle concentration and particle size of the resuspended solution were measured using nanoparticle tracking analysis. Based on the measured particle concentration, the suspension was further diluted with saline to 10 8 Concentration of particles / ml.

[0057] E. Lyophilization of exosomes

[0058] Add 8% dextran and 2% hyaluronic acid as freeze-drying protective agents to the diluted resuspension, mix thoroughly, and place at 4°C for 3 hours. Then dispense into sterilized vials and place in a freeze dryer for freeze drying, pre-freeze at -70°C for 7 hours, and then freeze-dry for 72 hours at a vacuum degree of 0-10pa and a temperature of -50°C to obtain freeze-dried mesenchymal stem cell exosomes.

[0059] The present application adds a prepared exosome-free culture medium to a culture bottle, inoculates mesenchymal stem cells, and collects the supernatant after culture; centrifuges the supernatant, collects the supernatant after centrifugation, and filters to obtain a filtrate; centrifuges the filtrate, removes the supernatant, and resuspends to obtain a resuspension; dilutes the resuspension, then adds a lyophilization protective agent, mixes thoroughly, and then freezes to obtain a mesenchymal stem cell exosome freeze-dried powder. The freeze-drying method of the mesenchymal stem cell exosomes of the present application complies with the aseptic preparation process and can be applied to large-scale automated production. The prepared mesenchymal stem cell exosome freeze-dried powder can maintain the structure and biological activity of the exosomes and can be stored for a long time.

[0060] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present application should be included in the protection scope of the present application.

Claims

1. A freeze-drying method for mesenchymal stem cell exosomes, characterized in that: The following steps are involved: Add the prepared exosome-free culture medium to the culture flask, inoculate mesenchymal stem cells, and collect the supernatant after culture; Centrifuging the supernatant, collecting the supernatant after centrifugation, and filtering to obtain a filtrate; Centrifuging the filtrate, removing the supernatant and resuspending to obtain a resuspended liquid; The resuspension is diluted, and then a freeze-drying protective agent is added, and the mixture is fully mixed and freeze-dried to obtain freeze-dried mesenchymal stem cell exosome powder.

2. The method according to claim 1, characterized in that The lyoprotectants include dextran and hyaluronic acid.

3. The method according to claim 2, characterized in that The amount of dextran used is 5%-10% of the final concentration of the resuspension after dilution, and the amount of hyaluronic acid used is 1%-4% of the final concentration of the resuspension after dilution.

4. The method according to claim 1, characterized in that: The freeze-drying procedure is as follows: the freeze dryer is balanced at 4°C for 2-3h, pre-frozen at -70°C for 6-8h, and then freeze-dried at a vacuum degree of 0-10Pa and a temperature of -50°C to -40°C for 60-72h.

5. The method according to claim 1, characterized in that The amount of the exosome-free culture medium is 25-35 ml.

6. The method according to claim 1, characterized in that The seeding density of the mesenchymal stem cells is 7000-10000 / cm 2 .

7. The method according to claim 1, characterized in that The culture conditions of the mesenchymal stem cells are: cultured at saturated humidity, 5% CO2, and 37°C for 3-4 days until the cells cover the bottom of the culture bottle.

8. The method according to claim 1, characterized in that The supernatant was centrifuged at 10000-12000 g for 30-60 min at 4°C.

9. The method according to claim 1, characterized in that: The supernatant after the centrifugation was filtered using a 0.22 μm filter.

10. The method according to claim 1, characterized in that The filtrate is centrifuged at 100,000-120,000 g for 60-80 min.

11. The method according to claim 1, characterized in that: The supernatant was removed and the cells were resuspended in physiological saline.

12. The method according to claim 1, characterized in that The resuspension was diluted with physiological saline to a concentration of 10 8 -10 9 Particles / ml.

13. A freeze-drying protective agent, characterized in that The invention comprises dextran and hyaluronic acid, wherein the dextran dosage is 5%-10% of the final concentration of the lyophilized liquid, and the hyaluronic acid dosage is 1%-4% of the final concentration of the lyophilized liquid.